<DOC>
	<DOCNO>NCT00000933</DOCNO>
	<brief_summary>Some people take azithromycin prevent MAC ( Mycobacterium avium Complex , bacterial infection common HIV-infected person ) find carry antibiotic-resistant bacteria ( germ grow despite presence drug use kill ) . The purpose study see people take azithromycin carry antibiotic-resistant bacteria people choose delay MAC preventive therapy . When bacteria like Streptococcus ( type bacteria cause pneumonia meningitis ) frequently expose antibiotic , bacteria become resistant drug . MAC preventive therapy use antibiotic , make difficult treat infection cause bacteria become resistant HIV-infected person . If MAC preventive therapy delay , Streptococcus body may less likely develop resistance . Therefore , patient get Streptococcus infection , easy treat resistant antibiotic .</brief_summary>
	<brief_title>Effects MAC Preventive Therapy Disease-Causing Bacteria HIV-Infected Patients : A Substudy CPCRA 048</brief_title>
	<detailed_description>Streptococcus pneumoniae lead cause bacteremia , pneumonia , meningitis , otitis medium United States . Prior 1987 , organism uniformly susceptible penicillin ; since , however , increase number isolates resistant penicillin , well common antibiotic , identify . Frequent exposure antibiotic document important risk factor emergence resistant organisms HIV-infected patient , likely uninfected people colonize antibiotic-resistant strain S. pneumoniae . This substudy first examine effect withdraw delay initiation prophylaxis ( case , MAC prophylaxis ) prevalence antibiotic-resistant pneumococcus prospective manner . Study participant subset enrol CR-MAC Protocol ( CPCRA 048 ) . Oropharyngeal swab take baseline 4 month randomization , use isolate S. pneumoniae culture . These isolates test susceptibility macrolides , penicillin , cephalosporin , quinolones , TMP-SMX . The rate pneumococcal colonization baseline 4 month randomization determine used estimate impact defer MAC prophylaxis carriage antibiotic-resistant S. pneumoniae .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Mycobacterium avium-intracellulare Infection</mesh_term>
	<criteria>Inclusion Criteria You may eligible study : Are enrol CPCRA 048 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Mycobacterium avium-intracellulare Infection</keyword>
	<keyword>Antibiotics , Macrolide</keyword>
	<keyword>Azithromycin</keyword>
	<keyword>Drug Administration Schedule</keyword>
	<keyword>Drug Resistance , Microbial</keyword>
	<keyword>Carrier State</keyword>
	<keyword>Streptococcus pneumoniae</keyword>
</DOC>